Network
ANZICS Clinical Trials Group
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 4 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
75%
3 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed trials have results
Key Signals
1 recruiting
Enrollment Performance
Analytics
Phase 3
2(66.7%)
Phase 4
1(33.3%)
3Total
Phase 3(2)
Phase 4(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT04588311Phase 3Recruiting
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
Role: collaborator
NCT03133377Phase 3Completed
Treatment of Invasively Ventilated Adults With Early Activity and Mobilisation
Role: collaborator
NCT05298982Enrolling By Invitation
The TEAM Long-Term Cohort Study (A Sub-study of TEAM(III))
Role: collaborator
NCT00221013Phase 4Completed
Augmented Vs. Normal Renal Replacement Therapy in Severe Acute Renal Failure (ARF).
Role: collaborator
All 4 trials loaded